Paclitaxel induces prolonged activation of the Ras/MEK/ERK pathway independently of activating the programmed cell death machinery.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Biological Chemistry

• Publication date

  2001-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0016-5085(08)83290-8PMID 11278851
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The taxanes: an update.

  2000cited by this paper
• Extracellular regulated kinase (ERK)-dependent regulation of sialomucin complex/rat Muc4 in mammary epithelial cells

  2000cited by this paper
• Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells.

  2000cited by this paper
• A Scaffold Protein in the c-Jun NH2-terminal Kinase Signaling Pathways Suppresses the Extracellular Signal-regulated Kinase Signaling Pathways*

  2000cited by this paper
• The MEK1–ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice

  2000cited by this paper
• Sustained activation of p42/p44 mitogen-activated protein kinase during recovery from simulated ischaemia mediates adaptive cytoprotection in cardiomyocytes.

  2000cited by this paper
• The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.

  2000cited by this paper
• Differential feedback regulation of the MAPK cascade underlies the quantitative differences in EGF and NGF signalling in PC12 cells

  2000cited by this paper
• Deficiency in caspase-9 or caspase-3 induces compensatory caspase activation

  2000cited by this paper
• Effect of Extracellular Signal-regulated Kinase on p53 Accumulation in Response to Cisplatin*

  2000cited by this paper
• Molecular Recognition of Taxol by Microtubules

  2000cited by this paper
• Akt/Protein Kinase B Isoforms Are Differentially Regulated by Epidermal Growth Factor Stimulation*

  2000cited by this paper
• Synergistic anti‐tumoral effect of paclitaxel (taxol)+AS101 in a murine model of B16 melanoma: Association with ras‐dependent signal‐transduction pathways

  2000cited by this paper
• Extracellular signal-regulated kinases are involved in the antiapoptotic effect of endothelin-1.

  2000cited by this paper
• Microtubule-interfering Agents Stimulate the Transcription of Cyclooxygenase-2

  2000cited by this paper
• Sequential activation of ERK and repression of JNK by scatter factor/hepatocyte growth factor in madin-darby canine kidney epithelial cells.

  2000cited by this paper
• Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells.

  2000cited by this paper
• A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin.

  2000cited by this paper
• Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways.

  2000cited by this paper
• Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis.

  2000cited by this paper
• Taxol reduces cytosolic E‐cadherin and β‐catenin levels in nasopharyngeal carcinoma cell line TW‐039: Cross‐talk between the microtubule‐ and actin‐based cytoskeletons

  2000cited by this paper
• CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin

  2000cited by this paper
• Taxol mediates serine phosphorylation of the 66-kDa Shc isoform.

  2000cited by this paper
• Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.

  2000cited by this paper
• Involvement of p21Waf1 in mediating inhibition of paclitaxel-induced apoptosis by epidermal growth factor in MDA-MB-468 human breast cancer cells.

  2000cited by this paper
• Anisomycin affects both pro- and antiapoptotic mechanisms in PC12 cells.

  2000cited by this paper
• Cell death beyond apoptosis

  2000cited by this paper
• Protein kinase activation by warm and cold hypoxia‐reoxygenation in primary‐cultured rat hepatocytes–JNK1/SAPK1 involvement in apoptosis

  2000cited by this paper
• Hydrogen Peroxide Activation of Multiple Mitogen‐Activated Protein Kinases in an Oligodendrocyte Cell Line

  1999cited by this paper
• Cleavage of Automodified Poly(ADP-ribose) Polymerase during Apoptosis

  1999cited by this paper
• Paclitaxel in the treatment of esophageal cancer.

  1999cited by this paper
• Differential regulation of mitogen-activated protein kinases by microtubule-binding agents in human breast cancer cells

  1999cited by this paper
• Screening of a library of phage-displayed peptides identifies human bcl-2 as a taxol-binding protein.

  1999cited by this paper
• Use of a photoactivatable taxol analogue to identify unique cellular targets in murine macrophages: identification of murine CD18 as a major taxol-binding protein and a role for Mac-1 in taxol-induced gene expression.

  1999cited by this paper
• Sustained Activation of the Mitogen-activated Protein Kinase Pathway

  1999cited by this paper
• Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers

  1999cited by this paper
• Microtubules and signal transduction.

  1999cited by this paper
• Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase*

  1998cited by this paper
• Taxanes propagate apoptosis via two cell populations with distinctive cytological and molecular traits.

  1998cited by this paper
• c‐jun N‐terminal kinase is involved in AUUUA‐mediated interleukin‐3 mRNA turnover in mast cells

  1998cited by this paper
• Rap1 mediates sustained MAP kinase activation induced by nerve growth factor

  1998cited by this paper
• Taxol-induced p34cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells.

  1998cited by this paper
• Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases.

  1998cited by this paper
• Macrophages resistant to endogenously generated nitric oxide-mediated apoptosis are hypersensitive to exogenously added nitric oxide donors: dichotomous apoptotic response independent of caspase 3 and reversal by the mitogen-activated protein kinase kinase (MEK) inhibitor PD 098059.

  1998cited by this paper
• Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis*

  1998cited by this paper
• Role of mitogen-activated protein kinase in taxol-induced apoptosis in human leukemic U937 cells.

  1998cited by this paper
• Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C

  1998cited by this paper
• Caspases: the executioners of apoptosis.

  1997cited by this paper
• Prenylation-dependent Association of Ki-Ras with Microtubules

  1997cited by this paper
• p38 Mitogen-activated Protein Kinase Phosphorylates Cytosolic Phospholipase A2 (cPLA2) in Thrombin-stimulated Platelets

  1996cited by this paper
• Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice

  1996cited by this paper
• The Ras-related GTPase Rac1 Binds Tubulin (*)

  1996cited by this paper
• Isolation of MEK5 and Differential Expression of Alternatively Spliced Forms *

  1995cited by this paper
• PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*)

  1995cited by this paper
• Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation.

  1995cited by this paper
• The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.

  1995cited by this paper
• Taxol stabilizes microtubules in mouse fibroblast cells.

  1980cited by this paper

• In silico investigation of Toxicodendron succedaneum phytochemicals as extracellular signal-regulated kinase 2 inhibitors for non-small cell lung cancer therapy

  2025cites this paper
• KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma

  2025cites this paper
• The Emerging Role of Natural Products in Cancer Treatment

  2024cites this paper
• Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα–TRAF3–TAK1–MAPK axis

  2024cites this paper
• Cancer-associated fibroblasts regulate mitochondrial metabolism and inhibit chemosensitivity via ANGPTL4-IQGAP1 axis in prostate cancer

  2024cites this paper
• Pharmacological Features and Therapeutic Implications of Plumbagin in Cancer and Metabolic Disorders: A Narrative Review

  2024cites this paper
• The Triterpenoid CDDO-Methyl Ester Reduces Tumor Burden, Reprograms the Immune Microenvironment, and Protects from Chemotherapy-Induced Toxicity in a Preclinical Mouse Model of Established Lung Cancer

  2024cites this paper
• Tannic Acid and Ethyl Gallate Potentialize Paclitaxel Effect on Microtubule Dynamics in Hep3B Cells

  2023cites this paper
• Azafuramidines as Potential Anticancer Agents: Pro-apoptotic Profile and Cell Cycle Arrest.

  2023cites this paper
• Paclitaxel exerts antiplatelet and antithrombotic activities: Additional benefit from use of paclitaxel-coated balloons and -eluting stents in coronary revascularization and prevention of in-stent restenosis.

  2023cites this paper
• Cobimetinib Sensitizes Cervical Cancer to Paclitaxel via Suppressing Paclitaxel-Induced ERK Activation

  2022cites this paper
• Nicotinic receptors modulate antitumor therapy response in triple negative breast cancer cells

  2022cites this paper
• The role of curcumin against paclitaxel-induced oxidative stress and DNA damage in testes of adult male rats

  2022cites this paper
• Combinatorial effects of melatonin and paclitaxel differ depending on the treatment scheme in colorectal cancer in vitro.

  2022cites this paper
• Synergistic effect of Paclitaxel and Curcumin in nano-formulations on U87 and A549 cancer cell lines

  2022cites this paper
• Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents.

  2022cites this paper
• Research on the Mechanism of HRP Relieving IPEC-J2 Cells Immunological Stress Based on Transcriptome Sequencing Analysis

  2022cites this paper
• Mixed Effects and Mechanisms of Cannabinoids for Triple-Negative Breast Cancer Treatment

  2021cites this paper
• Thymic Immunosuppressive Pentapeptide (TIPP) Showed Anticancer Activity in Breast Cancer and Chronic Myeloid Leukemia Both In Vitro and In Vivo.

  2021cites this paper
• Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition

  2021cites this paper
• Simultaneous estimation of paclitaxel and curcumin in nano-formulation: Stability analysis of drugs, optimization and validation of HPLC method

  2021cites this paper
• Differential methylation and expression of genes in the hypoxia-inducible factor 1 signaling pathway are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors and with preclinical models of chemotherapy-induced neuropathic pain

  2020cites this paper
• Kinase shRNA screening reveals that TAOK3 enhances microtubule-targeted drug resistance of breast cancer cells via the NF-κB signaling pathway

  2020cites this paper
• Recent Advances in Elucidating Paclitaxel Resistance Mechanisms in Non-small Cell Lung Cancer and Strategies to Overcome Drug Resistance.

  2020cites this paper
• The Involvement of the RhoA/ROCK Signaling Pathway in Hypersensitivity Reactions Induced by Paclitaxel Injection

  2019cites this paper
• An ultrasensitive fiveplex activity assay for cellular kinases

  2019cites this paper
• Dual-responsive nanoparticles based on chitosan for enhanced breast cancer therapy.

  2019cites this paper
• Plumbagin Increases Paclitaxel-Induced Cell Death and Overcomes Paclitaxel Resistance in Breast Cancer Cells through ERK-Mediated Apoptosis Induction.

  2019cites this paper
• Antagonistic anticancer effect of paclitaxel and digoxin combination

  2019cites this paper
• Inhibiting ERK/Mnk/eIF4E broadly sensitizes ovarian cancer response to chemotherapy

  2018cites this paper
• HDAC4 degradation by combined TRAIL and valproic acid treatment induces apoptotic cell death of TRAIL-resistant head and neck cancer cells

  2018cites this paper
• Paclitaxel suppresses proliferation and induces apoptosis through regulation of ROS and the AKT/MAPK signaling pathway in canine mammary gland tumor cells

  2018cites this paper
• Large-Scale Analysis of Microtubule Pharmacology via Phosphoproteomics and High-Content Imaging

  2018cites this paper
• Enhanced Chemotherapeutic Efficacy of Paclitaxel Nanoparticles Co-delivered with MicroRNA-7 by Inhibiting Paclitaxel-Induced EGFR/ERK pathway Activation for Ovarian Cancer Therapy.

  2018cites this paper
• Alteration of microRNA profiling in sphere-cultured ovarian carcinoma cells.

  2018cites this paper
• SELECTIVE INHIBITION OF KRAS SIGNALING BY COMBINATION OF LOW DOSE RAPAMYCIN AND PACLITAXEL IN VIVO

  2018cites this paper
• Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects

  2017cites this paper
• AKT‐phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1‐MAPK interaction

  2017cites this paper
• Tunicamycin potentiates paclitaxel-induced apoptosis through inhibition of PI3K/AKT and MAPK pathways in breast cancer

  2017cites this paper
• Effect of curcumin and paclitaxel on breast carcinogenesis.

  2016cites this paper
• Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways.

  2016cites this paper
• Voies de signalisation impliquées dans la sensibilisation des tumeurs mammaires au docétaxel par les acides gras polyinsaturés n-3

  2015cites this paper
• Ras activation revisited: role of GEF and GAP systems

  2015cites this paper
• Underexpressed CNDP2 Participates in Gastric Cancer Growth Inhibition through Activating the MAPK Signaling Pathway

  2014cites this paper
• Underexpressed CNDP 2 Participates in Gastric Cancer Growth Inhibition through Activating the MAPK Signaling Pathway

  2014cites this paper
• Suprafenacine, an Indazole-Hydrazide Agent, Targets Cancer Cells Through Microtubule Destabilization

  2014cites this paper
• Wentilactone B induces G2/M phase arrest and apoptosis via the Ras/Raf/MAPK signaling pathway in human hepatoma SMMC-7721 cells

  2013cites this paper
• Novel facts about FAK: new connections to drug resistance?

  2013cites this paper
• A combination of paclitaxel and siRNA-mediated silencing of Stathmin inhibits growth and promotes apoptosis of nasopharyngeal carcinoma cells

  2013cites this paper
• Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel.

  2013cites this paper
• A new diaryl urea compound, D181, induces cell cycle arrest in the G1 and M phases by targeting receptor tyrosine kinases and the microtubule skeleton

  2012cites this paper
• Effects of Paclitaxel on EGFR Endocytic Trafficking Revealed Using Quantum Dot Tracking in Single Cells

  2012cites this paper
• Die Bedeutung der Mikrotubuli-Integrität für das olfaktorische Lernen und Gedächtnis der Honigbiene (Apis mellifera)

  2011cites this paper
• Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment.

  2011cites this paper
• 多西他赛与吉非替尼序贯应用对人肺腺癌细胞SPC-A1生长及信号蛋白的影响

  2011cites this paper
• Secretory Leukocyte Protease Inhibitor Antagonizes Paclitaxel in Ovarian Cancer Cells

  2010cites this paper
• XRP6258‐induced gene expression patterns in head and neck cancer carcinoma

  2010cites this paper
• MyD88 expression and anti-apoptotic signals of paclitaxel in epithelial ovarian cancer cells

  2010cites this paper
• Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.

  2009cites this paper
• KSP inhibitor ARRY-520 as a substitute for Paclitaxel in Type I ovarian cancer cells

  2009cites this paper
• Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells

  2009cites this paper
• THE USE OF INFRARED SPECTROSCOPY FOR FOLLOWING DRUG-MEMBRANE INTERACTIONS: PROBING PACLITAXEL (TAXOL)-CELL PHOSPHOLIPID SURFACE RECOGNITION

  2009cites this paper
• TAXUS Liberté attenuates the risk of restenosis in patients with medically treated diabetes mellitus: results from the TAXUS ATLAS program.

  2009cites this paper
• Nuclear Factor-κB Inhibition by Parthenolide Potentiates the Efficacy of Taxol in Non–Small Cell Lung Cancer In vitro and In vivo

  2009cites this paper
• Synergistic anti‐tumor effect of paclitaxel with CRM197, an inhibitor of HB‐EGF, in ovarian cancer

  2009cites this paper
• Differential impact of fibroblasts on the efficient cell death of lung cancer cells induced by paclitaxel and cisplatin

  2008cites this paper
• Inhibition of the Ras-Net (Elk-3) pathway by a novel pyrazole that affects microtubules.

  2008cites this paper
• PPAR-γ Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors

  2008cites this paper
• Chemosensitization in non-small cell lung cancer cells by IKK inhibitor occurs via NF-κB and mitochondrial cytochrome c cascade

  2008cites this paper
• Tumor Immunotherapy in Melanoma

  2008cites this paper
• The growth inhibition of hepatocellular and cholangiocellular carcinoma cells by gemcitabine and the roles of extracellular signal-regulated and checkpoint kinases.

  2008cites this paper
• The effect of p53 gene expression on the inhibition of cell proliferation by paclitaxel

  2008cites this paper
• The PIM1 Kinase Is a Critical Component of a Survival Pathway Activated by Docetaxel and Promotes Survival of Docetaxel-treated Prostate Cancer Cells*

  2008cites this paper
• Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.

  2008cites this paper
• Paclitaxel: a review of adverse toxicities and novel delivery strategies

  2007cites this paper
• Microtubules in apoptosis induction: are they necessary?

  2007cites this paper
• Gene Expression Profiling of Cylindrospermopsin Toxicity

  2007cites this paper
• Calpain inhibition stimulates caspase-dependent apoptosis induced by taxol in NIH3T3 cells.

  2007cites this paper
• Translation regulation after taxol treatment in NIH3T3 cells involves the elongation factor (eEF)2.

  2007cites this paper
• The growth inhibition of liver cancer cells by paclitaxel and the involvement of extracellular signal-regulated kinase and apoptosis.

  2007cites this paper
• Therapeutic angiogenesis inhibits or rescues chemotherapy-induced peripheral neuropathy: taxol- and thalidomide-induced injury of vasa nervorum is ameliorated by VEGF.

  2007cites this paper
• BMS-275183-induced gene expression patterns in head and neck carcinoma.

  2007cites this paper
• Mitogen-activated protein kinases and chemoresistance in pancreatic cancer cells.

  2006cites this paper
• Comparative Effects of Paclitaxel and Rapamycin on Smooth Muscle Migration and Survival: Role of Akt-Dependent Signaling

  2006cites this paper
• Production of paclitaxel and the related taxanes by cell suspension cultures of Taxus species.

  2006cites this paper
• Requirement for ERK activation in acetone extract identified from Bupleurum scorzonerifolium induced A549 tumor cell apoptosis and keratin 8 phosphorylation.

  2005cites this paper
• Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim

  2005cites this paper
• Paclitaxel Impairs Endothelial Cell Adhesion But Not Cytokine-Induced Cellular Adhesion Molecule Expression

  2005cites this paper
• Differential effects of interferon alpha-2b and beta on the signaling pathways in human liver cancer cells

  2005cites this paper
• Docetaxel Associated Pathways in Cisplatin Resistant Head and Neck Squamous Cell Carcinoma: A Pilot Study

  2005cites this paper
• IFN-gamma enhances paclitaxel-induced apoptosis that is modulated by activation of caspases 8 and 3 with a concomitant down regulation of the AKT survival pathway in cultured human keratinocytes.

  2005cites this paper
• Untersuchungen zur Chemo- und Radiosensitivität und deren Auswirkungen auf Zellzyklus, Apoptoseinduktion und Genexpression in neuroendokrinen Pankreastumorzellen

  2005cites this paper
• Activation of mitogen activated protein kinase pathways and melanogenesis by novel nitro-derivatives of 7-hydroxycomarin in human malignant melanoma cells.

  2005cites this paper
• Stat3 upregulates MEK5 expression in human breast cancer cells

  2004cites this paper
• B23/Nucleophosmin Serine 4 Phosphorylation Mediates Mitotic Functions of Polo-like Kinase 1*

  2004cites this paper
• Daphnetin induced differentiation of human renal carcinoma cells and its mediation by p38 mitogen-activated protein kinase.

  2004cites this paper
• Induction of Survivin Expression by Taxol (Paclitaxel) Is an Early Event, Which Is Independent of Taxol-mediated G2/M Arrest*

  2004cites this paper
• Enhancement of Ad‐p53 Therapy with Docetaxel in Head and Neck Cancer

  2004cites this paper
• ZD1839 Modulates Paclitaxel Response in Renal Cancer by Blocking Paclitaxel-Induced Activation of the Epidermal Growth Factor Receptor–Extracellular Signal-Regulated Kinase Pathway

  2004cites this paper
• Modulation of Janus kinase 2 by cisplatin in cancer cells.

  2004cites this paper